These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 14580043)

  • 21. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.
    Binder WJ; Brin MF; Blitzer A; Schoenrock LD; Pogoda JM
    Otolaryngol Head Neck Surg; 2000 Dec; 123(6):669-76. PubMed ID: 11112955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum Toxin versus Placebo: A Meta-Analysis of Prophylactic Treatment for Migraine.
    Bruloy E; Sinna R; Grolleau JL; Bout-Roumazeilles A; Berard E; Chaput B
    Plast Reconstr Surg; 2019 Jan; 143(1):239-250. PubMed ID: 30589800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.
    Blumenfeld A
    Headache; 2003 Sep; 43(8):853-60. PubMed ID: 12940806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and tolerability of a fixed combination of acetylsalicylic acid, paracetamol, and caffeine in patients with severe headache: a post-hoc subgroup analysis from a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study.
    Diener HC; Peil H; Aicher B
    Cephalalgia; 2011 Oct; 31(14):1466-76. PubMed ID: 21908446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Use of Botulinum Toxin Type A in Headache Treatment.
    Mathew NT; Kaup AO
    Curr Treat Options Neurol; 2002 Sep; 4(5):365-373. PubMed ID: 12162925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
    Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
    Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension.
    Wheeler AH
    Headache; 1998 Jun; 38(6):468-71. PubMed ID: 9664753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managing and treating tension-type headache.
    Freitag F
    Med Clin North Am; 2013 Mar; 97(2):281-92. PubMed ID: 23419626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study.
    Lipton RB; Stewart WF; Cady R; Hall C; O'Quinn S; Kuhn T; Gutterman D
    Headache; 2000; 40(10):783-91. PubMed ID: 11135021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin type A for the treatment of migraine.
    Aurora S
    Expert Opin Pharmacother; 2006 Jun; 7(8):1085-95. PubMed ID: 16722818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Headache classification by history has only limited predictive value for headache episodes treated in controlled trials with OTC analgesics.
    Diener HC; Pfaffenrath V; Pageler L; Peil H; Aicher B; Lipton RB
    Cephalalgia; 2009 Feb; 29(2):188-93. PubMed ID: 18823361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
    Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
    Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin type A and acute drug costs in migraine with triptan overuse.
    Christie SN; Giammarco R; Gawel M; Mackie G; Gladstone J; Becker WJ
    Can J Neurol Sci; 2010 Sep; 37(5):588-94. PubMed ID: 21059503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Potential antinociceptive mechanisms of botulinum toxin].
    Aoki KR; Francis J; Jost WH
    Schmerz; 2006 Sep; 20(5):381-2, 384-7. PubMed ID: 16819667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical management of adult headache.
    Freitag FG; Schloemer F
    Otolaryngol Clin North Am; 2014 Apr; 47(2):221-37. PubMed ID: 24680490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials.
    Loo LS; Ailani J; Schim J; Baygani S; Hundemer HP; Port M; Krege JH
    J Headache Pain; 2019 Jul; 20(1):84. PubMed ID: 31340760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group.
    Silberstein S; Mathew N; Saper J; Jenkins S
    Headache; 2000 Jun; 40(6):445-50. PubMed ID: 10849039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins.
    Schaefer SM; Gottschalk CH; Jabbari B
    Toxins (Basel); 2015 Jul; 7(7):2615-28. PubMed ID: 26184313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.